Fortis Frontier Reinvents Itself as Cash Shell After Diagnostics Sale

MyHealthChecked PLC ( (GB:FORF) ) has provided an update.

Fortis Frontier PLC, an AIM-quoted cash shell formerly known as MyHealthChecked PLC, has transitioned away from its previous at-home diagnostics operations following the sale of Concepta Diagnostics Limited to Boots UK for £2.375m. As a result, the group’s balance sheet is now predominantly cash-based, with net assets of £5.38m at 31 December 2025, and the board is concentrating on tightly managing overheads and cash burn.

The company reported a total comprehensive loss of £1.63m for 2025, reflecting discontinued operations, director termination costs and reduced revenue from its former testing business. Having bought back 435,000 shares below net asset value and now attracting multiple potential reverse takeover approaches, Fortis Frontier is positioning itself as a clean cash shell, with the board carefully assessing transaction opportunities amid global economic uncertainty while shareholders await clarity on its next strategic move.

Fortis Frontier has published its audited final results and is distributing its annual report and AGM notice to investors ahead of a 28 April 2026 meeting in Cheltenham. The company has also secured a VAT repayment related to historic COVID PCR testing, bolstering cash flows and underpinning its current strategy of disciplined capital management during this transition phase.

The most recent analyst rating on (GB:FORF) stock is a Sell with a £8.00 price target. To see the full list of analyst forecasts on MyHealthChecked PLC stock, see the GB:FORF Stock Forecast page.

Spark’s Take on FORF Stock

According to Spark, TipRanks’ AI Analyst, FORF is a Neutral.

The score is driven primarily by weak financial performance (steep revenue decline, negative gross profit, and cash burn in 2024), with only partial support from a low-debt balance sheet. Technicals add pressure with a clear downtrend and negative MACD, while valuation is difficult to justify due to negative earnings and no dividend support.

To see Spark’s full report on FORF stock, click here.

More about MyHealthChecked PLC

Fortis Frontier PLC, formerly MyHealthChecked PLC, is now an AIM Rule 15 cash shell after selling its sole trading subsidiary, Concepta Diagnostics Limited, to Boots UK in November 2025. The business previously focused on at-home healthcare and wellness tests and a supporting digital platform, but the group is now primarily a cash vehicle while the board evaluates new strategic options to maximise shareholder value.

Average Trading Volume: 48,087

Technical Sentiment Signal: Sell

Current Market Cap: £3.86M

See more data about FORF stock on TipRanks’ Stock Analysis page.